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Abstract
Background: Cognitive behavior therapy (CBT) is widely regarded as an effective treatment for obsessive
compulsive disorder (OCD), but access to CBT therapists is limited. Internet-based CBT (ICBT) with therapist support
is a way to increase access to CBT but has not been developed or tested for OCD. The aim of this study was to
evaluate ICBT for OCD.
Method: An open trial where patients (N = 23) received a 15-week ICBT program with therapist support consisting
of psychoeducation, cognitive restructuring and exposure with response prevention. The primary outcome was the
Yale-Brown Obsessive Compulsive Scale (Y-BOCS), which was assessed by a psychiatrist before and immediately
after treatment. Secondary outcomes were self-rated measures of OCD symptoms, depressive symptoms, general
functioning, anxiety and quality of life. All assessments were made at baseline and post-treatment.
Results: All participants completed the primary outcome measure at all assessment points. There were reductions
in OCD symptoms with a large within-group effect size (Cohen’s d = 1.56). At post-treatment, 61% of participants
had a clinically significant improvement and 43% no longer fulfilled the diagnostic criteria of OCD. The treatment
also resulted in statistically significant improvements in self-rated OCD symptoms, general functioning and
depression.
Conclusions: ICBT with therapist support reduces OCD symptoms, depressive symptoms and improves general
functioning. Randomized trials are needed to confirm the effectiveness of this new treatment format.
Trial Registration: ClinicalTrials.gov: NCT01348529
Keywords: Cognitive behavior therapy, Internet, obsessive compulsive disorder
Background
Obsessive compulsive disorder (OCD) is a chronic con-
dition characterized by obsessions and/or compulsions
(e.g. fear of dirt, need for symmetry, compulsory check-
ing) [1]. OCD is associated with lowered quality of life,
social isolation [1] and a large economic burden on
society [2]. The lifetime prevalence is estimated to be 2-
3% [3]. First line treatments are serotonin reuptake inhi-
bitors and cognitive behavior therapy (CBT) [4].
Although there is substantial evidence for the effective-
ness of CBT [5], there is generally limited access to
CBT therapists [6,7]. Therefore, as evidence-based
psychological treatment is scarce, it is essential to
develop more time- and cost-efficient treatments for
OCD patients who do not receive CBT. Self-help treat-
ments have the potential to reduce therapist time and
make the treatment more accessible to patients [8]. Self-
help treatments with therapist support has been found
to be equally effective as face-to-face treatments [9]
whereas studies without the therapist have lower effects
[10].
Self-help treatments for OCD have been developed
and evaluated previously [11-14] with medium to large
effect sizes. One specific type of self-help treatment is
computer-based CBT. In a small study by Clark et al.
[15], a computer program was tested for OCD patients
with checking and washing rituals. The program
included interactive animations to model exposure with
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ritual prevention (ERP) and resulted in reduced washing
and checking rituals [15]. Another example of a compu-
ter-based treatment for OCD is “BT-steps” [16], which
includes education, assessment, and self-exposure tech-
niques. In BT-steps, the patient works with a self-help
book and reports progress with the treatment using an
automated phone interactive-voice-response. BT-steps
has been evaluated in four different trials [17-20]. The
results from these trials show that computer-based CBT
is effective for reducing OCD symptoms but that the
treatment format may be inferior to traditional CBT,
mainly due to higher dropout rates. One of the studies
[20] also shows that dropout rates decreases if telephone
support is added. Hence, therapist support appears ben-
eficial in this treatment format which is in line with
what has been observed for several other conditions
[21].
CBT can be delivered via the Internet. Internet-based
CBT (ICBT) with therapist support is a type of compu-
terized treatment in which the patient logs onto a web-
site and works with written self-help material and
homework assignments [21,22]; the patient’s work with
the treatment is supported by regular contact with an
online therapist. One advantage of ICBT is that the text
material, work sheets, self-rating questionnaires and
therapist contact are integrated into a single system.
The main function of the therapist is to provide support
through clarifying information, monitoring progress, giv-
ing feedback on homework assignments and allowing
the patients access to the sequential treatment steps.
ICBT has been effective in randomized controlled trials
on a wide range of psychiatric and medical problems
[23-25], and has the advantage of saving therapist time
compared to traditional treatment. Therefore, ICBT has
the potential to be a cost-effective alternative for OCD
and increases treatment accessibility [26].
Previous self-help trials on OCD have been strictly
computer-based and/or have featured very limited thera-
pist support. This is important as evidence suggest that
self-help treatments are more effective when guided by
a therapist [21]. There are, to our knowledge, no pub-
lished data on ICBT with therapist support in the treat-
ment of OCD. Therefore, an open pilot study was
conducted to evaluate the value of ICBT with therapist
support for OCD before moving on to a controlled trial.
A treatment program for OCD was developed in which
patients receiving treatment were expected to improve
on measures of OCD, global functioning, quality of life
and secondary psychiatric symptoms.
Method
Participants
The study was approved by the regional ethics commit-
tee in Stockholm. Informed written consent was
obtained from all study participants. Participants were
recruited in Stockholm by referral from primary care
physicians, mental health professionals and self-referral.
Information about the study was published on the offi-
cial web page of the clinic http://www.internetpsykiatri.
se.
To be eligible for inclusion, the following criteria had
to be fulfilled by the participants: (a) to agree not to
undergo any other psychological treatment for the dura-
tion of the study; (b) to have no history of CBT for
OCD during the last two years; (c) to fulfill the Diagnos-
tic and Statistical Manual of Mental Disorders 4th ed.
(DSM-IV) [27] criteria of OCD according to the struc-
tured clinical interview for mental disorders (SCID-I)
[28]; (d) to have no serious physical illness; (e) to have
constant dosage two months prior to treatment if on
prescribed psychotropic medication, and agree to keep
dosage constant throughout the study; (f) other comor-
bid disorders according to the Mini International Neu-
ropsychiatric Interview (MINI) [29] were acceptable but
the OCD diagnosis had to be primary; (g) no alcohol or
drug abuse dependency; (h) to have no history of psy-
chosis or bipolar disorder, (i) Yale-Brown Obsessive
Compulsive Scale (Y-BOCS) < 31 which is the estab-
lished cut-off for extreme OCD [30] and (j) OCD symp-
toms not primarily associated with hoarding. The reason
for the hoarding exclusion criterion was that the treat-
ment of hoarding differs substantially from other OCD-
related symptoms [31] and in the forthcoming DSM-V
[32], hoarding is proposed as a separate disorder. There-
fore, the inclusion of hoarders would potentially
decrease future ecological validity and clinical usefulness
of this study.
In the first stage of the recruitment process, partici-
pants conducted an Internet screening consisting of the
Y-BOCS (self-rating version) [33], Obsessive Compulsive
Inventory - Revised (OCI-R) [34], Montgomery Åsberg
Depression Rating Scale - Self report (MADRS-S) [35],
Alcohol Use Disorders Identification Test (AUDIT) [36],
and the Drug User Disorders Identification Test
(DUDIT) [37]. In the next step, participants were inter-
viewed over the telephone to determine whether they
met inclusion criteria a and b; obvious cases of non-
OCD were excluded in this step (e.g. patients with a pri-
mary diagnosis of trichotillomania). Of the 55 indivi-
duals screened, 34 individuals continued to a face-to-
face diagnostic interview with a psychiatrist (indepen-
dent assessor) who had extensive training in OCD diag-
nostics. Through the interview, it was determined
whether criteria c-j were fulfilled and OCD severity was
assessed with a clinician administered Y-BOCS [30].
Twenty-four of the interviewed participants fulfilled all
criteria and were included in the study. Two weeks after
inclusion, one participant reported serious problems
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with drug and alcohol abuse which had not been
reported at the psychiatrist visit. This participant was
retrospectively excluded from the study and all data
analyses. All 23 participants completed primary outcome
assessment with a psychiatrist at baseline and post-treat-
ment. All participants except one also completed the
self-rated outcome measures. The participant flow
throughout the trial is displayed in Figure 1 and the
demographic description of the participants is presented
in Table 1. Therapist time (i.e. time to read the reports
and write feedback) was logged automatically in the
treatment platform. The therapist was not allowed to do
any patient-related work (writing feedback etc.) outside
the treatment platform log system.
Outcome measures
Diagnosis and global functioning
The participants underwent a structured diagnostic
interview, in which SCID [28] was used for OCD and
MINI [38] for other diagnoses. The SCID has acceptable
reliability with Cohen’s Kappa coefficients ranging .70-
1.00 [28] and the MINI has high diagnostic concordance
with other diagnostic tools [38]. The reason for con-
ducting the SCID on OCD criteria was that the SCID
provides more detailed questions than the MINI. The
Clinical Global Impression Scale (CGI) [39] and Global
Assessment of Functioning (GAF) [27] were used to
measure global improvement. Although not previously
validated for an OCD population, both CGI [40] as well
as the GAF [41] have shown satisfactory reliability in
other psychiatric populations. Diagnostic and global
functioning was assessed during the psychiatric inter-
view at both baseline and post-treatment.
Yale Brown Obsessive Compulsive Scale (Y-BOCS)
The primary outcome measure was the clinician-admi-
nistered Y-BOCS [30], which is regarded as the gold
standard for assessing the severity of OCD symptoms
[42]. Y-BOCS comprises 10 items, rated on a 5-point
Likert scale ranging from 0 (no symptoms) to 4 (severe
symptoms). The total score ranges from 0 to 40 and
consists of two sub scores for compulsions (range 0 to
20) and obsessions (range 0 to 20). Y-BOCS has excel-
lent inter-rater reliability and moderate to good internal
consistency [30]. There are moderate correlations
between the clinician and the self-rating version of the
Y-BOCS, with the obsession subscale having lower con-
vergence between the two versions [43]. However,
another study has shown a correlation between the
Figure 1 Flowchart.
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computer and clinician administered Y-BOCS of .88
[33]. The clinician version of Y-BOCS was administered
at baseline and post-treatment by a psychiatrist and
administered as a self-rating questionnaire at screening,
baseline and post-treatment [33].
Obsessive Compulsive Inventory - Revised (OCI-R)
The secondary outcome measure of OCD symptoms
was the OCI-R which included 18 items measuring six
different symptom dimensions [34]. The OCI-R total
score has high test-retest reliability (alpha values from
.81 to .89) and high sensitivity to change, in relation to
the Y-BOCS [44]. The OCI-R was administered at
screening, baseline, post-treatment, and weekly during
treatment to monitor OCD symptoms.
Montgomery Åsberg Depression Rating Scale - Self report
(MADRS-S)
The MADRS-S is a 9-item questionnaire assessing
depressive symptoms [35]. The MADRS-S has good
test-retest reliability (.80 - .94) and correlates (r = .87)
with the Beck Depression Inventory, indicating accepta-
ble convergent validity [45]. Previous research has
shown that the psychometric properties of the MADRS-
S remains unchanged after transformation to online use
[46]. The MADRS-S was used at screening, baseline,
post-treatment and weekly during treatment to assess
and monitor depressive symptoms.
Penn State Worry Questionnaire (PSWQ)
The PSWQ is a 16-item inventory designed to assess
pathological worry. The PSWQ has high internal consis-
tency and good test-retest reliability [47] and the com-
puterised version has shown high convergence
compared to the paper and stencil version [48]. The
PSWQ was administered at baseline and post-treatment.
Euroqol (EQ-5D)
The euroqol (EQ-5D) is used as a generic measurement
of global functioning and quality of life [49]. The EQ-
5D is non-disease specific and measures five health
domains of importance to quality of life: mobility, self-
Table 1 Demographic description of the participants
Variable Treatment cohort
N %
Gender Women 15 65%
Men 8 35%
Age Mean age (SD) 39
Min-max 21-67
Occupational status Working full time 17 74%
Student 2 9%
Full-time sick-leave 1 4%
Unemployed 2 9%
Pensioner 1 4%
Earlier psychological treatment Psychodynamic Therapy 5 22%
Cognitive therapy 1 4%
Cognitive Behavior therapy 5 22%
Non-specific counseling 3 13%
None 9 39%
Education High school 8 35%
University < 3 years 2 9%
University ≥ 3 years 12 52%
PhD 1 4%
Psychotropic medication SSRI 4 17%
Benzodiazepines 4 17%
Psychiatric contact Mean length in years 1.93
Min-max 0-14
OCD duration Mean length in years 13
Min-max 4-56
Referral Self referral 13 57%
GP referral 4 17%
Mental health professional referral 6 26%
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care, usual activities, pain/discomfort, and anxiety/
depression [50]. The measure has good psychometric
properties including acceptable test-retest reliability over
7 to 10 days (intraclass coefficient = .82 - .83) and
acceptable convergent validity [51]. The computer admi-
nistered EQ-5D correlates highly (.85) with the paper
and pencil version [52]. The EQ-5D was administered at
baseline and post-treatment.
Quality of life Inventory (QOLI)
QOLI measures quality of life [53] and consists of 16
items covering different life domains, such as work and
health. QOLI has good test-retest reliability with alpha
coefficients of .80-.91 and good internal consistency
[53]. The online version of the QOLI has been com-
pared to the paper and pencil version with mixed results
[54,55]. The QOLI was administered at baseline and
post-treatment.
Treatment
The self-help manual consisted of 15 modules, compris-
ing 100 pages. The manual was written by the first
author (EA) and was inspired by a self-help book [56].
Six experienced clinical psychologists who worked at an
OCD clinic read the manual, gave written feedback, and
met for a three-hour focus group to discuss possible
improvements of the manual. The manual was further
developed after this feedback. The contents of the mod-
ules are presented in Table 2.
The manual was partly tailored to common OCD sub-
types (washing, checking, symmetry, and forbidden
thoughts). All participants read the same texts relating
to general psychoeducation and rationale for the treat-
ment, but specific examples of obsessions and compul-
sions were given according to the participants’ OCD
subtype. The participants had to submit homework
exercises after each module. One psychologist (EA) trea-
ted all participants and provided feedback and support
on homework assignments within 36 hours during
weekdays. The participants were given consecutive
access to the next module after completing quizzes and
registrations in the worksheets. The treatment lasted for
15 weeks and included e-mail contact only with the
therapist.
Statistical analysis
SPSS version 19.0 (SPSS inc., Chicago) was used for the
statistical analyses. Continuous variables were analyzed
by within-group t-tests with Bonferroni corrected alpha
levels, ordinal variables were analyzed by Wilcoxon’s
signed rank test, and nominal variables were analyzed
with McNemar’s test of change. Cohen’s d was used to
calculate within-group effect sizes using the formula
(Mpre - Mpost)/SDpooled. We used the Jacobson & Truax
criteria [57] to determine clinical significant
improvement using reliable change index with a cutoff
of 2 standard deviations below pre-treatment value. We
also used the 30% reduction criterion on the Y-BOCS
which is a less conservative estimate of clinical improve-
ment; the 30%-criterion has been used in previous stu-
dies and has the highest positive efficiency score (91%)
of agreeing with CGI change [58]. The sample size was
considered satisfactory as power calculations indicated
an 87% chance of detecting a significant pre-post differ-
ence, given an effect size of 0.6 with an alpha-level of
.05.
Results
Treatment adherence
The therapist spent a mean time of 92 minutes (SD =
43) per patient during the 15-week treatment (range:
25-203 minutes, median: 80 minutes). The average num-
ber of completed modules was 9.74 (SD = 3.93). Some
participants had daily contact with the psychologist to
report progress with the ERP but a majority of the parti-
cipants preferred weekly contact. Three participants did
not begin the ERP exercises and were therefore consid-
ered as dropouts. The reasons for not beginning ERP
reported by these participants at post-treatment assess-
ment were lack of time and difficulties getting started
with the active treatment. None of the participants
reported any changes in medication or parallel psycholo-
gical treatments at post-treatment assessment.
Treatment effectiveness
Primary outcome
The results are presented in Table 3. Significant reduc-
tions in OCD symptoms were found on the primary
outcome (Y-BOCS clinician version) (t 22 = 7.88, p <
.001) with a large effect size of 1.56.
Secondary outcomes
The results are presented in Table 3 and Figure 2. There
were significant improvements on the Y-BOCS (self-rat-
ing version) (t 21 = 5.93, p < .001) and the OCI-R (t 21 =
6.57, p < .001) with large effect sizes ranging from 1.30
to 1.39. In addition, there were improvements on GAF
(t 22 = 4.40, p < .001) and MADRS-S (t 21 = 5.87, p <
.001) with large effect sizes ranging from 0.93 to 1.06.
Results also revealed a non-significant trend (uncor-
rected) on the EQ-5D (t 21 = 1.83, p = .082) with a
small effect size of 0.24. The results of the QOLI and
PSWQ were non-significant.
Clinical significance and CGI
The number of clinically significant improvements using
Jacobson and Truax criteria [57] was 14 of 23 (61%) (p
< .001). The corresponding figure using the ≥ 30%
reduction criterion was 18 of 23 (78%) (p < .001) and 10
of the 23 (43%) participants no longer fulfilled the diag-
nostic criteria of OCD immediately after treatment (p <
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.001). There was a reduction of CGI-severity scores (Z =
3.49, p < .001); the CGI-improvement scores are pre-
sented in Figure 3.
Discussion
The aim of this open pilot study was to evaluate the
effects and feasibility of ICBT for OCD. The results
were in line with the previous findings on ICBT with
therapist support for anxiety disorders with large
within-group effect sizes on the primary outcome mea-
sures [59]. The within-group effect sizes for improve-
ments in OCD symptoms were large ranging from 1.30
to 1.56. There were also large effect sizes in general
functioning and depression and a small trend towards
increased quality of life with EQ-5D. The number of
participants meeting diagnostic criteria for OCD after
treatment decreased and 61% of the participants reached
the criteria for clinically significant improvement. Using
the less conservative 30% reduction criterion, the
response rate increased to 78%.
The effect sizes in this trial were in the same range as
the effects of traditional face-to-face CBT for OCD [5],
even though this trial used much less therapist time (92
minutes over the 15-week treatment) than traditional
face-to-face treatments, and had higher in-group effect
sizes than most trials with strictly computer-based treat-
ments [15,17-20]. One possible explanation for the large
effects in this trial was the high accessibility and possibi-
lity to have an intensive contact with the therapist dur-
ing treatment. Intensive contact and increased access to
the therapist have been investigated in face-to-face CBT
with effect sizes comparable to other trials of CBT for
OCD [60]. Furthermore, therapist input has been found
to be an important factor in ICBT [21]. The therapist in
this trial was very active and had sometimes daily com-
munication with the participants. As a result of this very
active therapist input, some participants worked inten-
sively with the treatment and achieved therapeutic bene-
fits (i.e. successful ERP) within a couple of weeks. In
addition, the screening and post-treatment assessment
interviews were conducted face-to-face by a psychiatrist
and this could also have affected the treatment adher-
ence and outcome.
If controlled trials confirm that ICBT with therapist
support is indeed effective for OCD, one possible venue
for future applications could be to combine face-to-face
Table 2 Summary of the content of the OCD treatment manual
Module 1
CBT and OCD explained
Treatment rationale is presented, including a description of OCD symptoms (obsessions and
compulsions), prevalence, and main principles of conducting an online CBT treatment. Different
fictional patient characters are introduced (each example represents a specific OCD symptom
dimension). The participant has the opportunity to follow one or all four characters (washing,
checking, symmetry, or violent thoughts). Homework: Register OCD symptoms in the Internet platform
diary.
Module 2
Assessing OCD symptoms with
the CBT model
The autonomic nervous system and its interaction with OCD symptoms is explained. Participants
begin to link obsessions and compulsions to the OCD circle and learn how to conduct a functional
analysis of their OCD problems. Each OCD circle is presented visually for each example character.
Homework: Continue OCD diary registrations and apply these to the OCD circle.
Module 3
Cognitive restructuring
Common OCD metacognitions are explained, such as inflated responsibility, absolute need for
certainty, thought-action fusion and exaggerated need to control. The focus is to register and discuss
meta cognitions with the psychologist from a functional perspective.
Homework: Continue OCD diary registrations and use these registrations to analyze meta cognitions
associated with obsessions.
Module 4
Establish treatment goals and exposure
hierarchy
Introduction to Exposure with response prevention (ERP). Different strategies for conducting ERP are
explained and examples given of treatment goals and different ways of constructing exposure
hierarchies for each example character.
Homework: register treatment goals and then construct an exposure hierarchy with the information from
these goals.
Module 5
Exposure with response prevention (ERP)
Different aspects of ERP are highlighted, along with common obstacles associated with ERP and how
to overcome them. The participant then chooses an ERP exercise at the bottom of the exposure
hierarchy.
Homework: Start ERP and report to the psychologist after two days.
Modules 6 - 11
ERP exercises
Each module focuses on certain ERP exercises with examples from each treatment character. The text
for each module is short (1-2 pages), as the focus is reporting and planning the weekly exposures.
Homework: Conduct daily ERP and report to the psychologist at least once per week.
Modules 12 - 13
ERP exercises. Establishing valued directions for
further improvements
The modules focus on daily ERP with further exercises added that are adopted from acceptance and
commitment therapy. These include establishing valued based goals and how they are applied in
daily exposure tasks.
Homework: Continue ERP. Establish valued based goals and applying them in daily exposure exercises.
Modules 14 - 15
Establishing relapse prevention plan
The treatment is summarized, and the participant learns the distinction between relapse and setback
and further treatment strategies. The participant establishes a relapse prevention program based on
his/her valued based goals.
Homework: Continue ERP. Sum the treatment and establish a relapse prevention plan.
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CBT with Internet support. This would combine two
important elements in therapy, the possibility to be flex-
ible using a face-to-face therapist and also opportunity
increase and reinforce ERP frequency between the ses-
sions. Other possible applications would be to add
weekly videoconference sessions as an adjunct to ICBT.
This would in turn expand the treatment arsenal and
further increase treatment accessibility for patients suf-
fering from OCD.
This study has several limitations. First, only one psy-
chologist (EA) treated all patients and the limited thera-
pist time achieved in this study is perhaps not fully
Table 3 Means, SDs, Effect Sizes, and p-values of Outcome Measures
Outcome measure M SD Effect size (CI, 95%) p-value
Y-BOCS (clin.) Pre 20.00 (5.20)
(n = 23) Post 10.00 (7.40) 1.56* (0.88 - 2.19) p < .001
Y-BOCS (self-r) Pre 20.14 (5.79)
(n = 22) Post 11.50 (7.44) 1.30* (0.64 - 1.92) p < .001
OCI-R Pre 21.60 (10.08)
(n = 22) Post 9.00 (7.84) 1.39* (0.72 - 2.02) p < .001
MADRS-S Pre 10.32 (5.61)
(n = 22) Post 4.50 (5.40) 1.06* (0.41 - 1.67) p < .001
PSWQ Pre 54.41 (12.46)
(n = 22) Post 50.04 (9.79) 0.39 (-0.21 - 0.97) p = .124
GAF Pre 57.87 (7.01)
(n = 22) Post 66.87 (11.83) 0.93* (0.30 - 1.52) p < .001
QOLI Pre 2.35 (1.42)
(n = 22) Post 2.42 (1.43) 0.05 (-0.54 - 0.63) p = .656
EQ-5D Pre 0.87 (0.19)
(n = 22) Post 0.91 (0.17) 0.24 (-0.35 - 0.83) p = .082
* Significant using Bonferroni corrected alpha values.
Y-BOCS = Yale-Brown Obsessive Compulsive Scales
OCI-R = Obsessive Compulsive Inventory - Revised
MADRS-S = Montgomery Åsberg Depression Rating Scale - Self Report
PSWQ = Penn State Worry Questionnaire
GAF = Global Assessment of Functioning
QOLI = Quality of Life Inventory
EQ-5D = Euroqol
Figure 2 Means and 95% confidence intervals of weekly OCD symptoms using OCI-R.
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generalizable to other therapists. However, the time to
treat the patients was about 9-10 minutes per module
which is in line with previous research studies of ICBT
with therapist support [61]. Second, the OCD symptom
ratings were lower in this sample than in other trials
where Y-BOCS baseline mean ratings range from 24 to
29 [62-64]. One possible consequence is that the effects
in this trial are lower because we had less room for Y-
BOCS change. Another possible consequence is that this
population was easier to treat because they had lower
symptom burden, Thus, the lower baseline means could
have affected the results in both ways. Third, we
excluded patients with extreme OCD (Y-BOCS > 31).
As this also affects the generalization of the results,
further trials including more severely impaired OCD
patients are needed to investigate the effects of ICBT for
OCD. Fourth, a majority (57%) of the participants was
self-referred and it is possible that we had a very moti-
vated patient population, affecting the generalization of
the results. However, Mataix-Cols et al. [65] found that
GP-referred patients have best treatment outcome com-
pared to self-referred or mental health professional
referred patients. Fifth, a majority of the participants
had university education ≥ 3 years, which also could
affect the generalization of the results. One interesting
future research topic would therefore be to investigate
treatment efficacy in ICBT for OCD in relation to both
referral type and educational level. Sixth, this study did
not include any long-term follow-up data. Our recom-
mendation for future studies is therefore to include fol-
low-up periods and further investigate long-term
efficacy of ICBT. Seventh, one of the outcome measures
(OCI-R) used in this study has not been validated for
online use. Thus, the administration format could have
affected the results. Finally, as this was a pilot study,
there was no randomization to a control condition,
which rendered it difficult to claim any improvements
were caused by the treatment alone. Furthermore, the
assessors were not blinded to time point. However,
OCD is regarded as a stable and often chronic disease
[1] and, considering the large effect sizes on both the
clinician and self-administered instruments, it is unlikely
the overall treatment results could be due spontaneous
remission.
Conclusions
Despite several limitations, the results suggest that ICBT
with therapist support has the potential to reduce OCD
symptoms, depressive symptoms and general function-
ing. Controlled trials are needed to further validate
ICBT for OCD.
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